NCT00534677View on ClinicalTrials.gov

The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

PHASE4CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

July 31, 2005

Conditions
Portal HypertensionCirrhosisHematemesisMelena
Interventions
DRUG

Terlipressin

2 mg stat \& then 1 mg q6h iv and Placebo of Octreotide

DRUG

Octreotide

Octreotide 50mcg/hr infusion \& a placebo of Terlipressin

Trial Locations (1)

74800

The Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT00534677 - The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed | Biotech Hunter | Biotech Hunter